Last updated:
07/20/2023
Years published: 1986, 1988, 1989, 1992, 1993, 1996, 1997, 1998, 1999, 2007, 2020
NORD gratefully acknowledges Timothy J. Fete, MD, MPH, NFED Scientific Advisory Council, Professor Emeritus, Department of Child Health, University of Missouri School of Medicine, and the National Foundation for Ectodermal Dysplasias, for assistance in the preparation of this report.
The ectodermal dysplasias (EDs) are a heterogeneous group of nearly 100 inherited disorders characterized by anomalies in at least two of the structures derived from the embryonic ectoderm, with at least one involving the skin appendages (hair, nails, sweat glands) or teeth. Other tissues derived from the primitive ectoderm that can be involved in EDs include the mammary glands, adrenal medulla, central nervous system, inner ear, retina, optic lens, pigment cells and branchial arch cartilages. Advances in molecular genetics and developmental biology have led to the identification of the causative genes and developmental pathways in at least 80 of the EDs.
Each of the nearly 100 EDs has its own set of clinical signs and symptoms. Commonly, the conditions will have one or more of the following associated findings:
The molecular causes of these diverse conditions involve many genes and multiple developmental pathways that are necessary for normal formation, structure and function of the ectodermal derivatives. This classification scheme does not include all disorders that affect two or more ectodermal derivatives. Genetic alterations of ED-associated genes that affect only one derivative of the ectoderm would be considered non-syndromic traits of the causative gene. Conditions already included as part of other classifications or groups of diseases (vesiculobullous disorders, palmoplantar keratodermas, etc.) are not included in the ED classification. Complex syndromes that have ED signs, but also major non-ED signs, such as trisomy 21, are also excluded from the ED classification scheme.
The genetic causes of greater than 50% of the ED’s have been determined. The classification scheme clusters the disorders based on genotype, molecular pathway and physical characteristics (phenotype). Categories are:
Conditions that meet the definition of ED but of unknown cause are grouped with other EDs that share the most similar phenotype. Once their genetic cause is identified, they can be classified with the appropriate category or become the anchor of a new cluster, depending on molecular etiology.
The reference listed below from Wright, et al provides a full listing of know ED conditions.
ED’s have been reported from essentially all races, ethnic groups and geographic regions.
Treatment depends upon the specific disease manifestations in the affected individual, and is largely aimed at minimizing symptoms. For most of the ED’s, multidisciplinary management is required, with involvement of primary care physicians, geneticists, dermatologists, multiple dental specialists, nutritionists, speech therapists, otolaryngologists, ophthalmologists, orthopedic surgeons and/or plastic surgeons.
There is ongoing research related to therapies for many of the ectodermal dysplasias. Consultation with a medical geneticist is recommended for most current recommendations.
Of note, intra-amniotic administration of a replacement fusion protein in X-linked hypohidrotic ectodermal dysplasia is showing promise in restoring sweat function and possibly increased dentition in ongoing clinical trials.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/
For information about clinical trials sponsored by private sources, contact:
https://www.centerwatch.com/
For more information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/
JOURNAL ARTICLES
Wright JT, Fete M, Schneider H, et al. Ectodermal dysplasias: Classification and organization by phenotype, genotype and molecular pathway. Am J Med Genet A. 2019 Mar;179(3):442-447.
INTERNET
Shah KN. Ectodermal Dysplasia. Medscape. Updated: Feb 11, 2019. www.emedicine.com/derm/topic114.htm Accessed March 5, 2020.
NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View reportGeneReviews has an article on this condition covering diagnosis, management, and inheritance. Each article is written by one or more experts on the specific disease and is reviewed by other specialists. The article contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. The GeneReviews database is managed by the University of Washington.
View reportPlease complete this form to access the requested resource.
